MyJournals Home  

RSS FeedsTargeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling (Cancer Gene Therapy)

 
 

28 january 2020 01:02:51

 
Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling (Cancer Gene Therapy)
 




 
215 viewsCategory: Oncology
 
Zinc finger protein 367 promotes metastasis by inhibiting the Hippo pathway in breast cancer (Oncogene)
Therapeutic effects of oligo-single-stranded DNA mimicking of hsa-miR-15a-5p on multiple myeloma (Cancer Gene Therapy)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Oncology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten